Xianwen Hu
-
- Multiple Myeloma Research and Treatments 4
-
- Radiopharmaceutical Chemistry and Applications 6
- Monoclonal and Polyclonal Antibodies Research 6
-
- Sarcoma Diagnosis and Treatment 9
-
- Soft tissue tumor case studies 4
- Urologic and reproductive health conditions 4
-
- Cardiac tumors and thrombi 4
-
- Ovarian cancer diagnosis and treatment 4
- Partner nations
- ChinaUnited States
In The Last Decade
Xianwen Hu
35 papers receiving 174 citations
Peers
Comparison fields: 5 of 45
- Hematology 34
- Radiology, Nuclear Medicine and Imaging 51
- Cancer Research 31
- Oncology 53
- Immunology and Allergy 11
Countries citing papers authored by Xianwen Hu
This map shows the geographic impact of Xianwen Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianwen Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianwen Hu more than expected).
Fields of papers citing papers by Xianwen Hu
This network shows the impact of papers produced by Xianwen Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianwen Hu. The network helps show where Xianwen Hu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xianwen Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 4 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 10 | |
| 14 | 2022 | 3 | |
| 15 | 2022 | 4 | |
| 16 | 2022 | 7 | |
| 17 | 2022 | 1 | |
| 18 | 2022 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2022 | 6 |
About Xianwen Hu
Xianwen Hu is a scholar working on Rheumatology, Radiology, Nuclear Medicine and Imaging, Oncology, Reproductive Medicine and Hematology, having authored 46 papers that have together received 179 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (9 papers), Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Multiple Myeloma Research and Treatments (4 papers), Soft tissue tumor case studies (4 papers), Cardiac tumors and thrombi (4 papers), Ovarian cancer diagnosis and treatment (4 papers) and Urologic and reproductive health conditions (4 papers). The work is most often cited by research in Hematology (34 citations), Radiology, Nuclear Medicine and Imaging (51 citations), Cancer Research (31 citations), Oncology (53 citations) and Immunology and Allergy (11 citations). Xianwen Hu has collaborated with scholars based in China and United States. Frequent co-authors include Jiong Cai, Pan Wang, Dandan Li, Haifeng Duan, Chu-Tse Wu, Guohu Di, Pan Wang, Changgeng Ruan, Xiaoping Du and Zhigang Liang. Their work appears in journals such as Frontiers in Medicine, Frontiers in Oncology, Medicine, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.